NCT07126717View on ClinicalTrials.gov

Acute Effects of Zynamite® S in Cognitive Function and Mood

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

June 2, 2025

Study Completion Date

June 9, 2025

Conditions
Cognitive PerformanceMood
Interventions
DIETARY_SUPPLEMENT

Placebo

Food-grade maltodextrin

DIETARY_SUPPLEMENT

Zynamite® S

Water-soluble mango leaf extract standardized to 60% of mangiferin

Trial Locations (1)

35118

University of Atlántico Medio, Tafira Baja

Sponsors

Lead Sponsor

Nektium Pharma SL
All Listed Sponsors
collaborator

University of Atlántico Medio

UNKNOWN

lead

Nektium Pharma SL

INDUSTRY

NCT07126717 - Acute Effects of Zynamite® S in Cognitive Function and Mood | Biotech Hunter | Biotech Hunter